The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Open accessAbstract
The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and difficult challenges facing global TB control. Patients who are infected with strains resistant to isoniazid and rifampicin, called multidrug-resistant (MDR) TB, are practically incurable by standard first-line treatment. In 2012, there were approximately 450,000 new cases and 170,000 deaths because of MDR-TB. Extensively drug-resistant (XDR) TB refers to MDR-TB strains that are resistant to fluoroquinolones and second-line injectable drugs. The main causes of the spread of resistant TB are weak medical systems, amplification of resistance patterns through incorrect treatment, and transmission in communities and facilities. Although patients harboring MDR and XDR strains present a formidable challenge for treatment, cure is often possible with early identification of resistance and use of a properly designed regimen. Community-based programs can improve treatment outcomes by allowing patients to be treated in their homes and addressing socioeconomic barriers to adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment typically involves standard antitubercular therapy, which is effective in most cases, although multidrug-resistant TB can complicate treatment [32,33,34].”
From Head and Neck Tuberculosis: A Rare Diagnosis and the Role of Surgical Biopsy and Histopathological Evaluation in Extrapulmonary Disease (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Gandhi, N. R., Moll, A. P., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J. R., & Friedland, G. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J. N., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C. J., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,098
Self-citationThe Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T. R., Pablos-Méndez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 937
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Deun, A. V., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 646
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 644
National survey of drug-resistant tuberculosis in China.
Zhao, Y.-L., Xu, S., Wang, L.-X., Chin, D., Wang, S.-F., Jiang, G., Xia, H., Zhou, Y., Li, Q., Ou, X.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108789 · Cited by 637
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M. V., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001300 · Cited by 532
Self-citationCommunity-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A. M., Castro, K. G., & Weyer, K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518665 · Cited by 483
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS. 2013. Second-Line antituberculosis drugs in children: A commis- sioned review for the World Health Organization 19th Ex- pert Committee on the Selection and Use of Essential Med- icines. World Health Organization, Geneva.
Cited by
Sorted by citations
Items 401–500 of 803
Asociación entre sobrepeso/obesidad y tuberculosis multidrogoresistente
Peinado, J., Lecca, L. W., Jiménez, J., Calderon, R. I., Yataco, R. M., Becerra, M. C., & Murray, M. B. (2023) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2023.401.12138 · Cited by 4
Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis
Hazra, S., Hazarika, R., & Patra, S. (2023) · Current Drug Targets · doi:10.2174/1389450124666230505145335 · Cited by 4
Dameria, D., Hulu, V. T., Siregar, S. D., Manalu, P., Samosir, F. J., Rambe, F. U. C., & Hasibuan, N. (2023) · JURNAL PROMOSI KESEHATAN INDONESIA · doi:10.14710/jpki.18.2.79-88 · Cited by 15
Mphaphuli, M. T., Sithole, M. N., Kumar, P., Kondiah, P. P. D., Mabrouk, M., & Choonara, Y. E. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105039 · Cited by 4
Arora, V. K., Jindal, S. K., Katiyar, S. K., Behra, D., Talwar, D., Sarin, R., Dhar, R., Mehta, P., Bhargava, S., Singhal, P., et al. (2023) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2023.10.002 · Cited by 4
Cai, Y., Gao, W., Wang, P., Zhang, G., Wang, X., Jiang, L., Zeng, J., Wang, Y., Wu, Z., & Li, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1266884 · Cited by 4
Chen, X., Sechi, L. A., & Molicotti, P. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03179-23 · Cited by 4
Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study
Puerto, G., Castro, C., Rubio, V. V., Fadul, S. E., & Montes, F. (2023) · Biomédica · doi:10.7705/biomedica.6842 · Cited by 4
Sharma, S., Yadav, P., Rana, M. M., & Chowdhury, P. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.125611 · Cited by 4
Hasan, Z., Razzak, S. A., Kanji, A., Shakoor, S., & Hasan, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2776346/v1 · Cited by 4
A systematic review of economic evaluations of pharmacological treatments for active tuberculosis
Nagar, S., Nicholls, D. A., & Dawoud, D. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1201512 · Cited by 3
Laskowska, M., Doskocz, M., Karczmarska, A., Pogoda, K., Olender, A., Gumbarewicz, E., Bogut, A., Gagoś, M., Stepulak, A., Dąbrowski, W., et al. (2025) · Applied Surface Science · doi:10.1016/j.apsusc.2025.165228 · Cited by 3
Chandrashekar, S., Prasad, S., R, R. M. N., Walia, S., Trikha, A., & Sadanandan, R. (2025) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2025.12.001 · Cited by 3
Development of machine learning models to identify potentially active compounds against tuberculosis
Rawat, A., Gupta, S., Pal, C., & Chowdhury, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-04668-z · Cited by 4
Kutscher, H. L., Tamblin, M., Smith, E., Shah, A., Kenney, P., & Reynolds, J. L. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01480-25 · Cited by 3
Pradeepa, S., Selvi, S. V., Chen, S., Radhakrishnan, S., Alagumalai, K., Rosaiah, P., & Hsiao, W. W. (2026) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2026.120057 · Cited by 3
Hossain, A., Asmar, A. E., Almheiri, A., Almheiri, H., & Alameddine, M. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13313-7 · Cited by 3
Chittipolu, M., Alves, E., Umarani, S., Chittipolu, A., Pattaluchetty, P., Rashmi, H. R., Chandan, R. S., Dixit, S. R., Osmani, R. A. M., Ravi, G., et al. (2026) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2026.2661000 · Cited by 3
Saxena, A., Bhagra, S., Das, S., Kaushik, N., & Saha, B. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108545 · Cited by 3
Maurya, S., Srivastava, R., Arfin, S., Hawthorne, S. J., Jha, N. K., Agrawal, K., Raj, S., Rathi, B., Kumar, A. J., Raj, R., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0437 · Cited by 4
Ghifary, M., Nugroho, M. A. A., Barokah, B., Purwarianti, A., Birowo, C. T., Machdi, I., Gaol, F. L., Purnama, I. K. E., Riandi, O., Azhar, T. N., et al. (2023) · Penerbit BRIN eBooks · doi:10.55981/brin.668 · Cited by 5
Sarkar, B., Jyotsna, Yadav, M., Sharma, P., Sharma, R. D., Singh, S., Chandramouli, A., Mehdiratta, K., Kumar, A., Kamat, S. S., et al. (2025) · eLife · doi:10.1101/2024.02.02.578554 · Cited by 3
Sonawane, K., Said, R. P., Lele, M., Chaudhari, H. K., & Hatvate, N. T. (2024) · ChemistrySelect · doi:10.1002/slct.202404094 · Cited by 3
Antibiotic Resistance in Mycobacterium Tuberculosis and Non-Tuberculous Mycobacteria
Wamalwa, R., Guyah, B., & Shaviya, N. (2024) · African Journal of Empirical Research · doi:10.51867/ajernet.5.4.83 · Cited by 3
Shafiq, A., Khan, H., Shahid, M., Fatima, N., & Khan, M. A. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.4.38 · Cited by 3
Drug-resistant tuberculosis treatment success predictors in Namibia
Nangombe, V., Amkongo, M., Godman, B., & Kibuule, D. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae211 · Cited by 3
Chouksey, M., Arya, V., & Takhelchangbam, N. D. (2023) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v14i7.53407 · Cited by 3
Zacarías-Hernández, J. L., Flores-Aréchiga, A., Támez-Guerra, R., Rivera-Morales, L. G., Castro‐Garza, J., Becerril-Montes, P., Vázquez-Cortés, C. G., de la O-Cavazos, M. E., Vázquez-Guillén, J. M., & Rodrı́guez-Padilla, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-90579-y · Cited by 3
Selvi, R. S., Murugesan, R. R., Wekalao, J., & Rajakannu, A. (2025) · Plasmonics · doi:10.1007/s11468-025-03178-y · Cited by 3
Extensively Drug Resistant Tuberculosis: A Mini Review
Singla, P., Singh, R., Sharma, M., Chaudhary, U., & Sharma, B. (2014) · Cited by 3
Wei, H., & Duan, X. (2021) · PubMed Central · Cited by 3
Sindhu, T., Sundarraj, R., Jeyakanthan, J., & Pal, D. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108347 · Cited by 3
Mumena, D. K., Kwenda, G., Ngugi, C. W., & Nyerere, A. K. (2022) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1542 · Cited by 3
Urgesa, K. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.43.78.31929 · Cited by 3
Synthesis and Bio‐evaluation of GR135486X Derivatives as Potent Anti‐Tubercular Agents
Sangu, K. G., Varakala, S. D., Krishna, E. V., Akhir, A., Saxena, D., Ahmad, M. N., Chopra, S., Misra, S., Sriram, D., & Rode, H. B. (2023) · ChemistrySelect · doi:10.1002/slct.202204186 · Cited by 3
Kim, S., Hesseling, A. C., Wu, X., Hughes, M. D., Shah, N. S., Gaikwad, S., Kumarasamy, N., Mitchell, E., León, M., Gonzáles, P., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283290 · Cited by 3
Gated Calcium Ion Channel and Mutation Mechanisms in Multidrug-Resistant Tuberculosis
D'Elia, J., & Weinrauch, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119670 · Cited by 3
Tuberculosis Burden in Bangladesh: Progressions and Challenges of Continuing Control Intervention
Ferdos, M. A., & Islam, M. T. (2023) · Saudi Journal of Medicine · doi:10.36348/sjm.2023.v08i08.007 · Cited by 3
Pomal, N. C., Bhatt, K., Patel, A. S., Dholariya, M. P., Kundariya, D. S., & Parikh, J. (2023) · Applied Nanoscience · doi:10.1007/s13204-023-02970-8 · Cited by 3
Zulqurnain, M., Aijijiyah, N. P., Wati, F. A., Fadlan, A., Azminah, A., & Santoso, M. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.140149 · Cited by 3
Nano vs Resistant Tuberculosis: Taking the Lung Route
Sharma, D., Pooja, P., Nirban, S., Ojha, S., Kumar, T., Jain, N., Mohamad, N., Kumar, P., & Pandey, M. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02708-3 · Cited by 3
Pace, D., Corvaglia, F., Lisi, C., Galli, L., & Chiappini, E. (2023) · Pathogens · doi:10.3390/pathogens12121439 · Cited by 3
Rv2741 Promotes Mycobacterium Survival by Modulating Macrophage Function via the IL-1α-MAPK Axis
He, X., He, Y., Deng, X., Lü, N., Li, A., Gao, S., He, S., Wang, Y., Fu, N., Wang, Z., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00790 · Cited by 3
Brintha, V. P., & Narayanan, M. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf139 · Cited by 3
Kalsum, S. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-153735 · Cited by 3
Kashongwe, I. M., Mbulula, L., Mawete, F., Anshambi, N., Maingowa, N., Kaswa, M. K., Kayembe, J. M., Lepira, F. B., & Kashongwe, Z. M. (2020) · Journal of Tuberculosis Research · doi:10.4236/jtr.2020.83010 · Cited by 3
Emerging and reemerging zoonotic diseases in India: A review
Dubey, S., Brahmbhatt, M. N., Singh, R. V., & Thakur, S. (2021) · Indian Journal of Comparative Microbiology Immunology and Infectious Diseases · doi:10.5958/0974-0147.2021.00033.7 · Cited by 3
Li, D., Dou, Z., Wu, Y., Qi, Y., Chen, J., & Gao, Y. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527666200505215346 · Cited by 3
Gao, W., Yang, N., Mei, X., Zhu, X., Hu, W., & Zeng, Y. (2021) · Europe PMC (PubMed Central) · Cited by 3
Naumov, A. G., & Shprykov, A. S. (2022) · PULMONOLOGIYA · doi:10.18093/0869-0189-2022-3204 · Cited by 3
Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multidrug Resistance Era!
Sahu, N. U., Shah, C. P., Machhar, J. S., & Kharkar, P. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00014-6 · Cited by 3
Nano‐Based Drug Delivery in Eliminating Tuberculosis
Gopinathan, A., Naik, S. S., Leela, K. V., & Ravi, S. (2023) · doi:10.1002/9781394167708.ch11 · Cited by 3
Sreekumar, S., Jyothi, J. L. B., Selvanose, L., Pani, S. C., Rajee, N. E., Aguero, S., Terreux, R., & Dhanasingh, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.07.631633 · Cited by 3
Mogoantă, C. A., Osman, A., Georgescu, A.-M., Mitroi, A. M., Busuioc, C. I., Tănase, I., Cioboată, R., Liliac, I. M., Cimpeanu, O. L., & Ciolofan, M. S. (2025) · Pathogens · doi:10.3390/pathogens14050479 · Cited by 2
“Treatment typically involves standard antitubercular therapy, which is effective in most cases, although multidrug-resistant TB can complicate treatment [32–34].”
Arfan, A., Asnawi, A., & Aman, L. O. (2024) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v7i1.5513 · Cited by 2
Dhivya, L. S., Manoharadas, S., Pandiaraj, S., Thiruvengadam, M., Viswanathan, D., & Rajakumar, G. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106945 · Cited by 2
Genomics and infectious diseases: Lessons learnt from the COVID-19 pandemic
Jolly, B., & Scaria, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91799-5.00020-6 · Cited by 2
Vummidi, V., & Talluri, S. (2025) · The Open Medicinal Chemistry Journal · doi:10.2174/0118741045367943250203071653 · Cited by 2
Cherezov, D., Dam, T., & Madabhushi, A. (2025) · SPIE Medical Imaging: Computer-Aided Diagnosis · doi:10.1117/12.3047396 · Cited by 2
Chen, B., Li, Y., Peng, Y., Zhou, L., Chen, X.-Y., Ren, Y.-L., Luo, D., Ling, Y., Zhou, Y., Jiang, J., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2496405 · Cited by 2
Gnanavelou, R., Perinbaraj, S., & Girija, K. R. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638362095250402180030 · Cited by 2
Mwanzui, F. M., Karanja, S. M., Muriithi, A. K., & Weyenga, H. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004131 · Cited by 2
Bharti, R., Mishra, S., & Pandey, A. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102354 · Cited by 2
Raina, R., Kar, D., Singla, M., Tiwari, S., Kumari, S., Aneja, S., Kumar, V., Banerjee, S., Goyal, S., Pal, R. K., et al. (2025) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x25004595 · Cited by 2
Recent advancements in drug development for pulmonary tuberculosis
Mukherjee, K., Saha, P., Ganguly, K. K., Chakraborty, S., Ghosh, S., & Kundu, G. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04415-y · Cited by 2
Kadima, M. G., Mishra, S., Kumar, G., Seboletswe, P., Kajee, A., Ankit, A., Roquet, F., Foubert, M., Kremer, L., Karpoormath, R. V., et al. (2025) · ChemMedChem · doi:10.1002/cmdc.202500398 · Cited by 2
Zhu, G., Feng, W., Li, F., & Zhang, X. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11766-w · Cited by 2
Marimuthu, M., Balasubramanian, S., Viswanathan, R. B., Parthiban, H. P., Malathi, M., & Kasirajan, G. (2025) · Structural Chemistry · doi:10.1007/s11224-025-02677-2 · Cited by 2
Chiu, W.-C., Chang, S., Lin, C., Chen, T.-W., & Fang, W.-H. (2025) · Bioengineering · doi:10.3390/bioengineering12121377 · Cited by 3
Ashayeripanah, M. (2026) · npj Vaccines · doi:10.1038/s41541-026-01394-z · Cited by 2
Acharya, B., Lamichhane, S., Brown, T. P., Chavent, M. G., & Im, W. (2026) · Biomacromolecules · doi:10.1021/acs.biomac.6c00446 · Cited by 2
Gari, S. B. V., & Peraman, R. (2021) · Pharmacognosy Journal · doi:10.5530/pj.2021.13.2 · Cited by 2
Comparative study of maternal and fetal outcome of tuberculosis in pregnancy in tertiary care centre
Budhewar, A. S., Anand, M. N., Anand, N. P., & Ubale, S. (2022) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20221281 · Cited by 2
Vijay, D. D., Meharaj, S. H. S., Jayanthi, S., Sujhithra, A., Vidhya, R., Meenakshi, N., & Shanmuganathan, A. (2022) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.16.3.42 · Cited by 2
Ogumbo, F., Odero, R., Odhiambo, B., Emojong, P., Okumu, A., Nonoh, J., Guya, B., & Wandiga, S. (2022) · East African Journal of Science Technology and Innovation · doi:10.37425/eajsti.v3i4.468 · Cited by 2
Sabarees, G., Gouthaman, S., Alagarsamy, V., Velmurugan, V., & Solomon, V. R. (2023) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023020206 · Cited by 2
Sharma, P., Kumar, A., & Meena, L. S. (2023) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2507 · Cited by 2
Bose, B., Kathirvel, V. V., Thirumaran, S., & Ayyanar, T. (2023) · Research Journal of Pharmacognosy and Phytochemistry · doi:10.52711/0975-4385.2023.00030 · Cited by 2
A review on plants possesses anti tubercular activity
Prajapati, A. K., Patil, P., & Joshi, S. (2023) · Journal of Preventive Medicine and Holistic Health · doi:10.18231/j.jpmhh.2023.012 · Cited by 2
Synthesis, Docking and In Vitro Evaluation of Spiroindoline‐3,2’‐Quinazoline Derivatives
Addu, N., Miriyala, H., Kapavarapu, R., Kolli, S. K., & Pal, M. (2023) · ChemistrySelect · doi:10.1002/slct.202302793 · Cited by 2
Toh, S.-I., Keisha, J. E., Wang, Y., Pan, Y.-C., Jhu, Y.-H., Hsiao, P., Liao, W., Chen, P.-Y., Ko, T., & Chang, C. (2023) · Communications Biology · doi:10.1038/s42003-023-05681-6 · Cited by 2
Ramdhani, D., & Kusuma, S. A. F. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023.v15s2.31 · Cited by 2
Altattan, B., Ullrich, J., Mattig, E., Poppe, A., Martins, R., & Bier, F. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-55289-x · Cited by 2
Suresh, P., Thulasidharan, S., Kumar, A., Sunil, S., Roy, M., Ramesh, V. P., Biswas, R., Kunoor, A., & Biswas, L. (2024) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.24-0042 · Cited by 2
Aman, M., Mir, A. A., Bashir, G., Wani, S., Khursheed, S. O., & Ahangar, I. N. (2024) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_69_24 · Cited by 2
Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future
Jain, A., Kumar, R., Mothsra, P., Sharma, A., Singh, A. K., & Kumar, Y. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266286294240610102911 · Cited by 3
Kaur, G., Gangwani, N., & Sharath, H. V. (2024) · Cureus · doi:10.7759/cureus.68309 · Cited by 2
Vo, T. T. B., Nguyen, D. T., Nguyen, T. V. H., Nguyen, H. T., Tran, H. T., & Nghiem, M. N. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10015-8 · Cited by 2
Predictors of treatment delay among drug resistant tuberculosis patients in Uganda
Kasozi, N. D., Charles, L., JohnBosco, A., & Henry, L. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10339-7 · Cited by 2
He, F., Wang, S., Wang, H., Ding, X., Huang, P., & Fan, X. (2025) · PeerJ · doi:10.7717/peerj.19112 · Cited by 2
Antimicrobial resistance: a global health crisis
Bhattacharyya, S. (2024) · MOJ Biology and Medicine · doi:10.15406/mojbm.2024.09.00228 · Cited by 2
Kurmi, S. P. C., & Karati, D. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00208-w · Cited by 2
Kumarachari, R. K., Guruvareddy, M., Phebe, M., Reddy, P. L., Nithin, M. S., Lakshmipathi, D., & Manasa, M. (2023) · Asian Journal of Chemistry · doi:10.14233/ajchem.2023.27482 · Cited by 2
Tuberculosis Multidrug Resistance (MDR-TB)
Silesky-Jiménez, J. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-33803-9_14 · Cited by 2
Kusmiati, T., Agustiyanto, C., Rampengan, V. R. C., & Soedarsono, S. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.4.25 · Cited by 2
Ofori, M., Danquah, C. A., Ossei, P. P. S., Rahamani, G., Nugbemado, I. N., Doe, P., & Ninkyi, T. K. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120513 · Cited by 2
Aruna, G. L., Kulkarni, R., Machaa, B., Jojula, M., Gunda, S. K., & Achaiah, G. (2020) · Asian Journal of Organic & Medicinal Chemistry · doi:10.14233/ajomc.2020.ajomc-p272 · Cited by 2
Das, N. P., & Panda, A. (2022) · National Journal of Laboratory Medicine · doi:10.7860/njlm/2022/53247.2591 · Cited by 2
Scott, N. R., Thirunavukkarasu, S., Rangel‐Moreno, J., Griggs, D. W., & Khader, S. A. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0027 · Cited by 2
Hassan, W. A., Abdel‐Gawad, M., & Abdelmohsen, A. S. (2022) · Al-Azhar Assiut Medical Journal · doi:10.4103/azmj.azmj_61_22 · Cited by 2
Metadata
- Authors
- Seung, K. J., Keshavjee, S., & Rich, M. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-04-27
- Volume
- 5
- Issue
- 9
- Pages
- a017863
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC4561400
- OpenAlex
- W2107340859
- Cited by
- 805
- References
- 32
- Citations by year
- 2026: 70 · 2025: 147 · 2024: 136 · 2023: 165 · 2022: 105 · 2021: 72 · 2020: 52 · 2019: 20 · 2018: 11 · 2017: 7 · 2016: 8 · 2015: 4
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- multidrug-resistant tuberculosis, extensively drug-resistant tuberculosis, isoniazid resistance, rifampicin resistance, fluoroquinolone resistance, second-line injectable drugs, transmission of drug-resistant strains, medication adherence, community-based treatment, global tuberculosis control, resistance monitoring
- MeSH terms
- Antitubercular Agents, Child, Community Health Services, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Isoniazid, Pregnancy, Pregnancy Complications, Infectious, Rifampin, Global Health, Drug Design, HIV Infections, Tuberculosis, Multidrug-Resistant, Fluoroquinolones, Extensively Drug-Resistant Tuberculosis, Coinfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
